New statistical study of Glioblastoma Multiforme Treatment market has been published by Absolute Markets Insights. Primary and secondary research techniques have been used to give an effective and accurate data to make an informative decision in the businesses. According to research report, this Glioblastoma Multiforme Treatment market is expected to reach CAGR by the end of this year. It is aggregated on the basis of several key factors, such as classification, specification, and applications of Glioblastoma Multiforme Treatment industries. This gives a detailed description about dynamic aspects of the businesses, such as shares, profit margin, and revenue that helps to give a basic idea of business structure.
Different internal or external driving factors have been included to give a brief understanding about growth of the companies. In addition to this, restraining factors are also mentioned to state the challenges in front of the businesses. In order to identify the global opportunities several methodologies have been listed in this report.
Top Key Players includes: Merck & Co., Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., DelMar Pharmaceuticals, NOXXON Pharma, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals, LLC, Amneal Pharmaceuticals, Karyopharm Therapeutics, Inc., Sumitomo Dainippon Pharma Oncology, Inc. (Boston Biomedical, Inc.), amongst others.
For More Information Click@ https://www.absolutemarketsinsights.com/reports/Global-Glioblastoma-Multiforme-Treatment-Market-2021---2029-923
In terms of revenue, global glioblastoma multiforme treatment market is expected to grow at a CAGR of 12.67% over the forecast period (2021 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Diseases have plagued humans since time immemorial, and the medical sciences sector is constantly trying to eradicate various diseases, or trying to find a cure for the same. One such disease that has drastically affected human beings, and is associated with is immense complications is brain tumor. Brain tumor results from a growth of abnormal cell division in the brain, resulting in unwarranted growth. Brain tumor can either be non-cancerous or cancerous. The growth of brain tumors is highly specific, and the growth rate, along with the location of the growth determines its effect on the human nervous system. Brain tumors that originate in the brain are referred to as primary brain tumors, whereas the tumor can reach the brain from different parts of the body through the spread of cancerous cells. The resulting brain tumor is called as secondary (metastatic) brain tumors. The most feared and common type of cancerous brain tumor is glioblastoma multiforme (GBM), and the prognosis for the same is extremely complicated. The treatment methods which are currently in existence has a low success rate, and scientists are increasingly trying to raise the survival rate through the inception of advanced treatment methods. GBM accounts for around 60% of the deaths related to brain tumors.
The tumor presents unique challenges due to various factors such as the localization of the tumor in the brain, high resistance to conventional therapy methods, tumor-stimulated seizures, transfer of malignant cells into adjacent tissues, and limited self-healing ability of the brain, amongst others. The tumor can be detected using sophisticated medical imaging techniques. Diagnostic imaging technology such as computed tomography (CT or CAT scan) and magnetic resonance imaging (MRI) are being used by highly trained medical professionals for identifying the location of the tumor for accurate treatment. Magnetic resonance spectroscopy (MRS), on the other hand, is used to study the chemical profile of the tumor, while intraoperative MRI is being used during surgical process for tumor removal. The rise in the number of GBM cases around the globe, coupled with growth in investment to increase the accuracy of treatment methods, is leading to the growth of the global glioblastoma multiforme treatment market.
Glioblastoma Multiforme Treatment Market Segmentation:
By Type of Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Tumor treating fields (TTF) therapy
- Targeted drug therapy
- Supportive (palliative) care
- Others
By Mode of Action
- Immunological
- Metabolic
- Pharmacological
By Demographic
- Kids
- Adults
By End Users
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical Companies
- Others
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin Americ
Contact Us:
Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
